Jul 19, 2022 | Knowledge Hub, Molecular Pathology
Limited multiplex PCR panels are useful when multiple organisms causing similar clinical presentations are in circulation. Rates of RSV (respiratory syncytial virus) have increased across all provinces in recent weeks while SARS-CoV-2 rates have also increased....
Jul 5, 2022 | Knowledge Hub, Molecular Pathology
PathCare has recently set up an efficient send away service for neuropathology molecular requests. This is to improve our test menu for this rapidly growing and specialised field as well as to improve the turn around time of tests such as MGMT promoter methylation. A...
Jun 23, 2022 | Knowledge Hub, Molecular Pathology
Rapid advances in the understanding of solid tumours has lead to exponential growth in the developement of molecularly-targeted therapies. Patients with tumours harbouring specific mutations may be candidates for specific therapies. Additionally, molecular testing...
Jun 23, 2022 | Knowledge Hub, Microbiology
The PathCare molecular laboratory is pleased to announce a new in-house NGS assay designed to have specific relevance in targeted therapy for ovarian, breast, prostate and pancreatic carcinoma. This assay is named the BRCAPlus assay and is designed to sequence the...
Jun 8, 2022 | Knowledge Hub, Microbiology
The National Institute for Communicable Diseases declared the start of the influenza season in week 17 (week ending 1 May) and influenza A positivity rates have continued to increase during May 2022, reaching 36.1% during week 22 nationally (week ending 5 June)....
